Literature DB >> 1309309

A clinical and radiologic study of primary liver cancer associated with extrahepatic primary cancer.

K Takayasu1, H Kasugai, S Ikeya, Y Muramatsu, N Moriyama, M Makuuchi, S Yamazaki, S Hirohashi.   

Abstract

In a consecutive series of 393 patients with excised and pathologically proven primary liver cancer (PLC)--including 374 hepatocellular carcinomas (HCC), nine cholangiocellular carcinomas (CCC), and ten mixed type of HCC and CCC--33 patients (8.4%) had one or two other malignancies in the extrahepatic organ(s). Of these, 29 had double cancers and four, triple cancers. This was synchronous in 11 patients, metachronous in 20 (including 18 with double cancers and two with triple cancers) and synchronous and metachronous in two with triple cancers. Metachronous cancer was found in 21 patients 1 year before hepatectomy for PLC and in three patients, 1 year after hepatectomy. The median age of PLC patients with multiple primary cancer (MPC) was 63.6 +/- 6.9 years; this was significantly greater than that of PLC patients without MPC (P less than 0.01). The associated cancer was gastric cancer in 11 patients (29.7%), colorectal cancer in six, pharyngeal cancer in four, and other cancers in ten different organs in 16. Thirteen of 22 patients had a history of blood transfusion. The incidence of liver cirrhosis in PLC associated with MPC (57.6%) was significantly lower than that without MPC (82.8%, P less than 0.01). The differential diagnosis of PLC from liver metastasis was possible retrospectively in 78.6% using sonograms, 79.3% using computed tomograms, and 91.3% using angiograms. The survival rates of patients with PLC with (n = 33) and without (n = 299) MPC who had undergone hepatectomy were 97.0% and 85.4% at 1 year, 55.5% and 59.5% at 3 years, and 40.5% and 40.1% at 5 years, respectively. There was no significant difference between the survival rates of those who underwent operations for PLC and extrahepatic primary cancer(s) synchronously and metachronously.

Entities:  

Mesh:

Year:  1992        PMID: 1309309     DOI: 10.1002/1097-0142(19920101)69:1<45::aid-cncr2820690110>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Malignant lymphoma of the stomach after chemotherapy for hepatocellular carcinoma.

Authors:  I Matsuo; K Omagari; N Ikuno; H Kinoshita; Y Onizuka; M Itsuno; T Nakayama; S Kohno
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

Review 2.  Familial heterozygous hypobetalipoproteinemia, extrahepatic primary malignancy, and hepatocellular carcinoma.

Authors:  A Lonardo; P Tarugi; G Ballarini; A Bagni
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

3.  Allelic loss of 14q32 in the pathogenesis of gastrointestinal and ampullary malignancies: mapping of the target region to a 17 cM interval.

Authors:  Yuan-Chang Dai; Chung-Liang Ho; Yi-Chang Tsai; Yung-Hsiang Hsu; Yu-Chuang Chang; Hsiao-Sheng Liu; Helen Hai-Wen Chen; Nan-Haw Chow
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-21       Impact factor: 4.553

4.  Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: a long-term follow-up study.

Authors:  Qing-An Zeng; Jiliang Qiu; Ruhai Zou; Yijie Li; Shengping Li; Binkui Li; Pinzhu Huang; Jian Hong; Yun Zheng; Xiangming Lao; Yunfei Yuan
Journal:  BMC Cancer       Date:  2012-04-17       Impact factor: 4.430

5.  Prevalence and outcomes of extrahepatic primary malignancy associated with hepatocellular carcinoma in a Korean population.

Authors:  Sukho Hong; Sook-Hyang Jeong; Sang Soo Lee; Jung Wha Chung; Sung Wook Yang; Seong Min Chung; Eun Sun Jang; Jin-Wook Kim; Jee Hyun Kim; Haeryoung Kim; Jai Young Cho; Yoo-Seok Yoon; Ho-Seong Han
Journal:  BMC Cancer       Date:  2015-03-18       Impact factor: 4.430

6.  Analysis of Extrahepatic Multiple Primary Malignancies in Patients with Hepatocellular Carcinoma according to Viral Infection Status.

Authors:  Keita Kai; Atsushi Miyoshi; Kenji Kitahara; Masanori Masuda; Yukari Takase; Kohji Miyazaki; Hirokazu Noshiro; Osamu Tokunaga
Journal:  Int J Hepatol       Date:  2012-12-01

7.  A case report of synchronous double primary liver cancers combined with early gastric cancer.

Authors:  Jae Young Chang; Byung-Ho Kim; Sung Wha Hong; Youn Wha Kim; Joo Hyeong Oh
Journal:  Korean J Intern Med       Date:  2003-06       Impact factor: 2.884

8.  Intracranial metastasis in a patient with hepatocellular carcinoma and gastric cancer.

Authors:  Akinobu Tawada; Tetsuhiro Chiba; Yoshihiko Ooka; Hajime Yokota; Naoya Kanogawa; Tenyu Motoyama; Tomoko Saito; Sadahisa Ogasawara; Eiichiro Suzuki; Naoyuki Hanari; Hisahiro Matsubara; Naokatsu Saeki; Michiyo Kambe; Takashi Kishimoto; Yukio Nakatani; Osamu Yokosuka
Journal:  Case Rep Oncol       Date:  2014-03-14

9.  Multiple Primary Malignancies in Patients With Hepatocellular Carcinoma: A Largest Series With 26-Year Follow-Up.

Authors:  Wei Xu; Wenjun Liao; Penglei Ge; Jinjun Ren; Haifeng Xu; Huayu Yang; Xinting Sang; Xin Lu; Yilei Mao
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

10.  Hepatocellular Carcinoma associated with Extra-hepatic Primary Malignancy: its Secular change, Clinical Manifestations and Survival.

Authors:  Kwong Ming Kee; Jing-Houng Wang; Chih-Chi Wang; Yu-Fan Cheng; Sheng-Nan Lu
Journal:  Sci Rep       Date:  2016-07-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.